Clinical Trial Update: DragonFly M2 Pivotal Study [NA]

View source ↗

Summary

The DragonFly M2 pivotal study for mitral valve regurgitation is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mitral Valve Regurgitation

Drugs mentioned

• DragonFly M2

Snippet

Sponsor: Hangzhou Valgen Medtech Co., Ltd | Conditions: Mitral Valve (MV) Regurgitation | NA | Status: NOT_YET_RECRUITING